RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure major autoimmune diseases at their source. RheumaGen focuses on editing the human leukocyte antigen (HLA), or “immune gene,” to develop one-time, curative cell and gene therapies. RheumaGen is headquartered in Aurora, Colorado. For more information, please visit rheumagen.com.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 200 Quebec St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.rheumagen.com
- Keywords
- Gene Therapy.
- HQ
- Denver, Colorado
Rheumagen Questions
Rheumagen's website is http://www.rheumagen.com
Rheumagen's LinkedIn profile is https://www.linkedin.com/company/rheumagen
Rheumagen has
6 employees.
View email and phone details for 6
employees at Rheumagen.
Rheumagen's industry is
Biotechnology Research
Rheumagen's top competitors are
Trampoline Pharma, Inc.,
Gelsana,
Darwin Biosciences,
Aoa Dx,
Think Bioscience,
Arpeggio Biosciences,
Enveda,
Vona Oncology,
Ajna Biosciences,
Onconaut Therapeutics Inc..
Rheumagen's categories are Biotechnology Research
Rheumagen's founding year is 2019
